Hu, S., Chen, Y., Xie, D., Xu, K., Fu, Y., Chi, W., . . . Huang, J. (2023, August). Nme2Cas9‐mediated therapeutic editing in inhibiting angiogenesis after wet age‐related macular degeneration onset. Clinical and Translational Medicine.
Chicago Style (17th ed.) CitationHu, Sihui, Yuxi Chen, Dongchun Xie, Kan Xu, Yunzhao Fu, Wei Chi, Haiying Liu, and Junjiu Huang. "Nme2Cas9‐mediated Therapeutic Editing in Inhibiting Angiogenesis After Wet Age‐related Macular Degeneration Onset." Clinical and Translational Medicine Aug. 2023.
MLA (9th ed.) CitationHu, Sihui, et al. "Nme2Cas9‐mediated Therapeutic Editing in Inhibiting Angiogenesis After Wet Age‐related Macular Degeneration Onset." Clinical and Translational Medicine, Aug. 2023.
Warning: These citations may not always be 100% accurate.
